
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>104-206</title>
    </head>

    <body>
        <h1>
        <a href="./104_205.html" rel="external" title="prev">≪</a>
        104-206
        <a href="./104_207.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>60歳男性。体重50kg、体表面積1.5m<sup>2</sup>。再発直腸がんで外来通院しながら以下の化学療法(処方1、2)を受けることになり、化学療法施用当日の夕方17時に来院した。医師の指示のもと薬剤師が施用準備のため安全キャビネットでオキサリプラチン点滴静注液を輸液Aで希釈した。</p>
<p>施用直前に患者が体調不良を訴えたため、翌日10時に再来し施用することになった。看護師は薬剤師に輸液Aで希釈したオキサリプラチン点滴静注液が翌日使用できることを確認し、速やかに冷所保存した。</p>
<p><img alt="" class="alignnone size-full wp-image-798" height="175.0" loading="lazy" sizes="(max-width: 570px) 100vw, 570px" src="data:;base64,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" width="399.0"/></p>
<h4>問206</h4>
<p>薬剤師がオキサリプラチン点滴静注液の希釈に用いた輸液Aはどれか。1つ選べ。</p>
<ol><li>5%ブドウ糖注射液　250mL</li><li>乳酸リンゲル液　500mL</li><li>生理食塩液　250mL</li><li>7%炭酸水素ナトリウム注射液　250mL</li><li>ビタミンB<sub>1</sub>・糖・電解質・アミノ酸液　500mL</li></ol>
<h4>問207</h4>
<p>オキサリプラチンの配位子及び配位子交換に関する記述のうち、誤っているのはどれか。1つ選べ。</p>
<p><img alt="" class="alignnone size-full wp-image-799" height="116.89999999999999" loading="lazy" src="data:;base64,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" width="187.6"/></p>
<ol><li>オキサリプラチンは配位子交換を原因とする配合変化を受ける。</li><li>配位子Aよりも配位子Bの方が交換しやすい。</li><li>配位子交換の起こりやすさは、交換相手となる配位子の種類、溶媒のpH及び温度に依存する。</li><li>DNA塩基との間で配位子交換を通じて架橋構造を形成することにより、抗がん活性を示す。</li><li>配位子Bは、3つの立体異性体のうちの1つである。</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問206：1問207：2
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問206</h4>
<p><span style="font-weight: 400;">オキサリプラチンは、<strong>Cl</strong><sup>– </sup></span><span style="font-weight: 400;"><strong> を含む溶液で分解</strong>します。また、<strong>塩基性溶液により分解</strong>します。従って「ブドウ糖溶液による希釈」です。</span></p>
<p><span style="font-weight: 400;">以上より、問206 の正解は 1 です。</span></p>
<h4>問207</h4>
<p><span style="font-weight: 400;">選択肢 1 は妥当な記述です。</span></p>
<p><span style="font-weight: 400;">選択肢 2 ですが<br/></span><span style="font-weight: 400;">COO なので、２つの酸素原子に電荷が非局在化している A よりも、B の窒素原子上の孤立電子対の方が、より強固な配位結合を構成していると考えられます。つまり、 A の方が緩い結合なので、交換しやすいのは配位子 A と考えられます。よって、選択肢 2 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 3 ~ 5 は妥当な記述です。<br/></span><span style="font-weight: 400;">不斉炭素２つで、立体異性体が ４つと見せかけて、対称面があるため、２つがメソ体で同一です。そのため、全部で３つの立体異性体と考えられます。</span></p>
<p><span style="font-weight: 400;">以上より、問207 の正解は 2 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    